US EditionPublished • loading... • Updated
The 2025 Drug Discovery & Development Pharma 50 Report: Deep Dives - Drug Discovery and Development
Summary by Drug Discovery and Development
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
The 2025 Drug Discovery & Development Pharma 50 Report: Deep Dives - Drug Discovery and Development
Oncology tops $84B, Mounjaro surges 124%: Your guide to the 2025 pharma landscape. FY2024 reset the competitive landscape in pharma. While oncology held its top sales standing, the rapid ascent of GLP-1s, market erosion from Humira biosimilars, and the advance of new modalities revised the new biopharma hierarchy. This deep-dive report builds on the Pharma… The post The 2025 Drug Discovery & Development Pharma 50 Report: Deep Dives appeared firs…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium